These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25495991)

  • 21. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA; Tse A; Ballermann M; Smith LK; Fouad K
    Eur J Neurosci; 2005 Aug; 22(3):735-44. PubMed ID: 16101755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possible mechanism of Parkinson's disease progressive damage and the preventive effect of GM1 in the rat model induced by 6-hydroxydopamine.
    Xu R; Zhou Y; Fang X; Lu Y; Li J; Zhang J; Deng X; Li S
    Brain Res; 2014 Dec; 1592():73-81. PubMed ID: 25285892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.
    Thomas Tayra J; Kameda M; Yasuhara T; Agari T; Kadota T; Wang F; Kikuchi Y; Liang H; Shinko A; Wakamori T; Vcelar B; Weik R; Date I
    Brain Res; 2013 Mar; 1502():55-70. PubMed ID: 23380533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparative study of inflammatory factor expression of phlegm-heat syndrome and phlegm-dampness syndrome model with acute exacerbation of chronic obstructive pulmonary disease].
    Mei X; Li JS; Zhou HY; Qiao CX; Li SY; Zhang YX
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jun; 25(6):343-6. PubMed ID: 23739567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coadministration of hydroxysafflor yellow A with levodopa attenuates the dyskinesia.
    Wang T; Duan SJ; Wang SY; Lu Y; Zhu Q; Wang LJ; Han B
    Physiol Behav; 2015 Aug; 147():193-7. PubMed ID: 25914172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
    Lane EL; Soulet D; Vercammen L; Cenci MA; Brundin P
    Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
    Wang Y; Wang HS; Wang T; Huang C; Liu J
    J Neurosci Res; 2014 Dec; 92(12):1733-45. PubMed ID: 24975553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
    Jin F; Wu Q; Lu YF; Gong QH; Shi JS
    Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.
    Glavan G
    Brain Res; 2008 Oct; 1236():216-24. PubMed ID: 18721798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration.
    Eriksson C; Tehranian R; Iverfeldt K; Winblad B; Schultzberg M
    J Neurosci Res; 2000 Apr; 60(2):266-79. PubMed ID: 10740232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
    Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
    Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of immunoglobulin on the neuronal expression of IL-1beta and IL-1ra and the neuronal death at hippocampus in rats with convulsion induced by pentylenetetrazol].
    An RZ; Yan GH; Piao DM; Yin YR; Chi YX
    Zhonghua Er Ke Za Zhi; 2005 Nov; 43(11):849-51. PubMed ID: 16316536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats.
    Rumpel R; Alam M; Klein A; Özer M; Wesemann M; Jin X; Krauss JK; Schwabe K; Ratzka A; Grothe C
    Neurobiol Dis; 2013 Nov; 59():230-43. PubMed ID: 23938762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.
    Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J
    Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
    Mo J; Zhang H; Yu LP; Sun PH; Jin GZ; Zhen X
    Neurobiol Aging; 2010 Jun; 31(6):926-36. PubMed ID: 18707801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?
    Lane EL; Cheetham SC; Jenner P
    Exp Neurol; 2006 Feb; 197(2):284-90. PubMed ID: 16005456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The experimental treatment of corneal graft rejection with the interleukin-1 receptor antagonist (IL-1ra) gene.
    Yuan J; Liu Y; Huang W; Zhou S; Ling S; Chen J
    PLoS One; 2013; 8(5):e60714. PubMed ID: 23723965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.
    Vorobyov V; Sengpiel F
    Exp Brain Res; 2008 Nov; 191(3):277-87. PubMed ID: 18682921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.